0
0
Moderna Partners with OpenAI to Revolutionize Medicine
Moderna, a prominent vaccine manufacturer, has recently joined forces with OpenAI, a major artificial intelligence (AI) company, in a groundbreaking partnership aimed at advancing the field of medicine. This collaboration, announced on Wednesday, involves embedding AI technology across Moderna’s various departments, including legal, research, and manufacturing, through the utilization of ChatGPT Enterprise.
The integration of AI into Moderna’s operations is expected to fuel the development of innovative solutions and drive the creation of 15 new products within the next five years, according to a report by the Wall Street Journal. Stéphane Bancel, the CEO of Moderna, expressed his enthusiasm for the partnership, highlighting its crucial role in enhancing the vaccine-maker’s business processes as it expands beyond COVID-19 vaccines to address other mRNA medicines targeting viruses and cancer.
Bancel emphasized the transformative potential of AI, drawing parallels to the impact of personal computers in the 1980s. He stressed that AI is poised to revolutionize daily life, with OpenAI at the forefront of this technological shift. The CEO’s vision includes Moderna employees utilizing AI tools like ChatGPT at least 20 times a day to streamline workflow and enhance productivity.
Empowering Employees with AI
The ongoing collaboration between Moderna and OpenAI stems from their mutual goal of harnessing AI capabilities to drive innovation in the healthcare sector. This alliance commenced in 2023 with the introduction of Moderna’s version of ChatGPT, known as mChat. Since its inception, Moderna has integrated over 750 generative pre-trained transformers (GPTs) into its operations, leveraging these AI models to automate various aspects of its business, including tailored GPTs for optimizing clinical trial dosages.
Sam Altman, the CEO of OpenAI, commended Moderna’s proactive approach in embracing AI to address complex challenges. Altman expressed eagerness to continue collaborating with Moderna in pioneering the development of next-generation medicines that cater to the needs of patients worldwide.
By pushing the boundaries of innovation and investing in cutting-edge technologies, Moderna and OpenAI are poised to redefine the future of medicine, setting new standards for research, development, and patient care.
Image/Photo credit: source url
